<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Systemic Hypertension</journal-id><journal-title-group><journal-title xml:lang="en">Systemic Hypertension</journal-title><trans-title-group xml:lang="ru"><trans-title>Системные гипертензии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2075-082X</issn><issn publication-format="electronic">2542-2189</issn><publisher><publisher-name xml:lang="en">Intermedservice Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">29179</article-id><article-id pub-id-type="doi">10.26442/SG29179</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Quality assessment of examination of patients with arterial hypertension in primary health care (according to the Russian arterial hypertension register data)</article-title><trans-title-group xml:lang="ru"><trans-title>Оценка качества обследования больных артериальной гипертонией в первичном звене здравоохранения (по данным российского Регистра артериальной гипертонии)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Oshchepkova</surname><given-names>E V</given-names></name><name xml:lang="ru"><surname>Ощепкова</surname><given-names>Е В</given-names></name></name-alternatives><bio xml:lang="ru"><p>д-р мед. наук, проф., рук. отд. Регистров сердечно-сосудистых заболеваний ФГБУ «НМИЦ кардиологии»</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Lazareva</surname><given-names>N V</given-names></name><name xml:lang="ru"><surname>Лазарева</surname><given-names>Н В</given-names></name></name-alternatives><bio xml:lang="ru"><p>канд. мед .наук., ст. науч. сотр. отд. Регистров сердечно-сосудистых заболеваний ФГБУ «НМИЦ кардиологии»</p></bio><email>n.lazareva@list.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Chazova</surname><given-names>I E</given-names></name><name xml:lang="ru"><surname>Чазова</surname><given-names>И Е</given-names></name></name-alternatives><bio xml:lang="ru"><p>акад. РАН, д-р мед. наук, проф., рук. отд. гипертонии, дир. ИКК им. А.Л.Мясникова, зам. ген. дир. по научной работе ФГБУ «НМИЦ кардиологии»</p></bio><email>chazova@hotmail.com</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">National Medical Research Center for Cardiology of the Ministry of Health of the Russian Federation</institution></aff><aff><institution xml:lang="ru">Институт клинической кардиологии им. А.Л.Мясникова ФГБУ «Национальный медицинский исследовательский центр кардиологии» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2017-06-15" publication-format="electronic"><day>15</day><month>06</month><year>2017</year></pub-date><volume>14</volume><issue>2</issue><issue-title xml:lang="en">VOL 14, NO2 (2017)</issue-title><issue-title xml:lang="ru">ТОМ 14, №2 (2017)</issue-title><fpage>29</fpage><lpage>34</lpage><history><date date-type="received" iso-8601-date="2020-04-09"><day>09</day><month>04</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2017, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2017, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://journals.eco-vector.com/2075-082X/article/view/29179">https://journals.eco-vector.com/2075-082X/article/view/29179</self-uri><abstract xml:lang="en"><p>Objective: to assess the quality of examination of patients with arterial hypertension in primary health care. Materials and methods. The study was carried out with the Arterial Hypertension Register method (a software with remote access, medical data inputs were made from medical records of patients with AH). The study included a selection of 29 126 patients with AH under care in primary health care in 22 regions of Russia in 2010-2014. 35% were males, females were older by 3.7 years (60.9±12.5 years and 64.6±12.0 years respectively, p&lt;0.05). Results. 1 stage AH was observed in 43% of patients; 2 stage - in 12%; 3 stage - in 3%. BP&lt;140/90 mm Hg was registered in 38% of patients. 80% of patients were under antihypertensive therapy. 4% of patients with AH lacked BP data in their medical records. Analysis of examinations of patients with AH showed that 63% of patients had data on family medical history of cardiovascular diseases in their medical cards; 78.1% - data on smoking status; 45% - on alcohol consumption; 83.8% - on physical activity level; 26.4% - on waist circumference; 46.5% - on height and bodyweight. Total cholesterol was identified in 86.4%, HDL cholesterol - in 25.5%, triglycerids - in 38.6%, glucose - in 85.3% and creatinine in 58.7% of patients with AH. ECG examination was done on 100% of patients, echo-cardiography - on 28.9%, duplex screening of brachiocephalic arteries - on 1% of patients with AH.Chronic heart failure (44.4%), coronary artery disease (45.6%) and Q-wave myocardial infarction in anamnesis (20.5%) were statistically more frequently observed in males. In females CHF was observed in 35.2% of patients, CAD - in 26.7% and Q-wave MI in anamnesis - in 5.5% of pts. II type diabetes mellitus was observed in 12.1% of males and in 17.8% of females with AH. Conclusion. The Register method study on a selection of patients with AH under care in primary health care in 2010-2014 shows that their examination with regard to medical history taking, cardiovascular risk factors and target organ damage assessment in patients with AH is nonoptimal. Further efforts are needed to educate physician primary care physician, family doctors and cardiologists on the methods of diagnostics and treatment of patients with AH according to the Russian guidelines on AH.</p></abstract><trans-abstract xml:lang="ru"><p>Цель исследования - оценка качества обследования больных артериальной гипертонией (АГ), проводимая врачами амбулаторно-поликлинического звена здравоохранения. Материалы и методы. Исследование проведено методом регистра АГ (компьютерная программа с удаленным доступом, медицинские данные вводились из амбулаторных карт больных АГ). Проанализирована выборка, состоящая из 29 126 больных АГ, наблюдаемых в поликлиниках и кардиодиспансерах 22 регионов Российской Федерации в 2010-2014 гг. Мужчин было 35%, женщины были старше на 3,7 года (60,9±12,5 и 64,6±12,0 года соответственно, р&lt;0,05). После трудоспособного возраста мужчин (60 лет и старше) и женщин (55 лет и старше) было 60 и 78% соответственно. Результаты. У 43% больных была 1-я степень АГ, 12% - 2-я, 3% - 3-я. У 38% больных уровень артериального давления ниже 140/90 мм рт. ст., у 4% отсутствовали показатели артериального давления в амбулаторных картах, 80% пациентов находились на антигипертензивной терапии. Анализ обследования больных АГ выявил, что у 63% уточнялся семейный анамнез сердечно-сосудистых заболеваний, статус курения - у 78,1%, опрошены 45% пациентов в отношении употребления алкоголя, опрос об уровне физической активности проводился у 83,8%, окружность талии измерена у 26,4%. Измерение роста и массы тела проводилось у 46,5% больных АГ. Общий холестерин определялся у 86,4%, холестерин липопротеидов высокой плотности - 25,5%, триглицериды - 38,6%, глюкоза плазмы натощак - 85,3%, креатинин - 58,7%. Электрокардиография проводилась у 100% больных, эхокардиография - 28,9%, дуплексное сканирование брахиоцефальных артерий - в 1% случаев. У мужчин с АГ достоверно чаще диагностирована хроническая сердечная недостаточность (44,4%), ишемическая болезнь сердца (45,6%) и Q-инфаркт миокарда (20,5%); у женщин с АГ - хроническая сердечная недостаточность (35,2%), ишемическая болезнь сердца (26,7%) и Q-инфаркт миокарда (5,5%). Сахарный диабет типа 2 диагностирован у 12,1% мужчин и 17,8% женщин с АГ. Выводы. Исследование методом регистра выборки больных АГ, наблюдающихся в первичном звене здравоохранения в 2010-2014 гг., показало неоптимальное обследование больных АГ и недостаточное выполнение Российских рекомендаций «Диагностика и лечение артериальной гипертонии». Необходима дальнейшая работа по обучению врачей - терапевтов, общей практики, семейных и кардиологов методам диагностики и лечения больных АГ в соответствии с Российскими рекомендациями по АГ.</p></trans-abstract><kwd-group xml:lang="en"><kwd>arterial hypertension</kwd><kwd>arterial hypertension register</kwd><kwd>target organ damage</kwd><kwd>cardiovascular risk factors</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>артериальная гипертония</kwd><kwd>Регистр артериальной гипертонии</kwd><kwd>диагностика</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>World Health Organization. World Health Statistics Annual. Geneva, Switzerland: World Health Organization, 1998.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Bor’ba s arterial’noi gipertoniei. Prevention of hypertension. Doklad Komiteta ekspertov VOZ. Vsemirnaya organizatsiya zdravookhraneniya. Report of WHO Expert Committee. World Health Organization Geneve, 1996.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Chazov E.I. Rukovodstvo po arterial’noi gipertonii. Guidelines for hypertension // Moscow; Media-Medika, 2005.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Chazova I.E. Oshchepkova E.V. Chikhladze N.M. Arterial’naya gipertoniya (printsipy diagnostiki i lecheniya). Arterial hypertension (principles of diagnosis and treatment). Moscow, 2005.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Britov A.N., Oganov R.G. The national program to combat arterial hypertension in the USSR. Therapeutic archive. 1985; 11: 67.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Оганов Р.Г., Чазова Л.В., Бритов А.Н. Кардиологич. вестн. 1986; 9 (1): 11.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Чазова И.Е., Жернакова Ю.В., Ощепкова Е.В. и др. Распространенность ФР сердечно - сосудистых заболеваний в российской популяции больных артериальной гипертонией. Кардиология. 2014; 10: 4-12.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Чазова И.Е., Ощепкова Е.В. Итоги реализации Федеральной целевой программы по профилактике и лечению артериальной гипертензии в России в 2002-2012 гг. Вестн. Российской академии медицинских наук. 2013; 2: 4-11.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Шальнова С.А., Деев А.Д., Вихирева О.В. и др. Распространенность артериальной гипертонии в России: информированность, лечение, контроль. Профилактика заболеваний и укрепление здоровья. 2001; 2: 3-7.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Heart disease and Stroke statistics - 2016 update: a report from the American Heart Association. Circulation 2016; 133.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Wolf-Maier K, Cooper R.S, Banegas J.R et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada and the United States. JAMA 2003; 289: 2363-9.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Pereira M, Lunet N, Azevedo A, Barros H. Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. J Hypertens 2009; 27: 963-75.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Клинические рекомендации «Диагностика и лечение артериальной гипертонии». Рабочая группа по подготовке текста: Чазова И.Е., Ощепкова Е.В., Жернакова Ю.В. Кардиологич. вестн. 2015; 1: 5-30.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>2013 ESH/ESC Guidelines for the management of arterial hypertension. J Hypertens 2013; 31 (7): 1281-357.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Dovgalevskii P.Ya., Oshchepkova E.V., Gridnev V.I. Register arterial hypertension. Ther Arch 2007; 1: 46-8.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Национальные рекомендации «Хроническая болезнь почек: основные принципы скрининга, диагностики, профилактики и подходы к лечению». Рабочая группа по подготовке текста: Смирнов А.В., Шилов Е.М. и др. Нефрология. 2012; 16 (1): 89-115.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Федеральная служба государственной статистики. http://www.gks.ru/</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>US Department of Health and Human Services. How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking - Attributable Disease: A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2010.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Brotons C, Bulc M, Sammut M.R et al. Attitudes toward preventive services and lifestyle: the views of primary care patients in Europe. The EUROPREVIEW patient study. Fam Pract 2012; 29 (Suppl. 1): i168-76.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Gual A, Zarco J et al. Early screening and brief intervention in alcohol misuse to improve the treatment of hypertension in primary care. Med Clin (Barc) 2016; 146 (2): 81-5.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Cláudia Rayanna Silva Mendes et al. Self - care comparison of hypertensive patients in primary and secondary health care services. Acta Paul Enferm 2015; 28 (6): 580-6.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Lein S, Burke L.E, Bray G.A et al. On behalf of the American Heart Association Council on Nutrition, Physical Activity, and Metabolism. Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism. Circulation 2004; 110: 2952-67.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Poirier P, Giles T.D, Bray G.A et al. On behalf of the American Heart Association; Obesity Commit - tee of the Council on Nutrition, Physical Activity, and Metabolism. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006; 113: 898-918.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Tedrow U.B, Conen D, Ridker P.M et al. The long - and short - term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (women’s health study). J Am Coll Cardiol 2010; 55: 2319-27.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Reiner Z, Catapano A.L, de Backer G et al. ESC/EAS. Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 2011; 32: 1769-818.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Henry R.M, Kostense P.J, Bos G et al. Mild renal insufficiency is associated with increased cardiovascular mortality: the Hoorn Study. Kidney Int 2002; 62: 1402-7.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Ощепкова Е.В., Долгушева Ю.А., Жернакова Ю.В. и др. Распространенность нарушения функции почек при артериальной гипертонии (по данным эпидемиологического исследования ЭССЕ-РФ). Системные гипертензии. 2015; 12 (3): 19-24.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Da Silva L.S, Cotta R.M.M, Moreira T.R et al. Hidden prevalence of chronic kidney disease in hypertensive patients: the strategic role ofprimaryhealthcare. J Publichealth 2016; 140: 250-7.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Coresh J, Selvin E, Stevens L.A et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-47.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Asia pacific Cohort Studies Collaboration. The effects of diabetes on the risk of major cardiovascular diseases and death in the Asia - Pacific region. Diabetes Care 2003; 26: 360-6.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Kim M-J, Lim N-K, Park H-Y. Relationship between prehypertension and chronic kidney disease in middle - aged people in Korea: the Korean genome and epidemiology study. BMC Public Health 2012; 12: 960.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Klag M.J, Whelton P.K, Randall B.L et al. End - stage renal disease in African - American and white men.16-year MRFIT findings. JAMA 1997; 277 (16): 1293-8.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Martinez M.A, Sancho T. Prevalence of left ventricular hypertrophy in patients with mild hypertension in primary care: impact of echocardiography on cardiovascular risk stratification. Am J Hypertens 2003; 6 (Issue 7): 556-63.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Saltykova M.M, Oshchepkova E.V, Ataullakhanova D.M et al. Electro cardiographs diagnosis of hypertrophyof left ventricular myocardium in patients with hypertension. Therapeutic Archive. 2006; 78 (12): 40-5.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Бойцов С.А., Калинина А.М. Диспансеризация взрослого населения как механизм выявления сердечно - сосудистых заболеваний и формирования диспансерного наблюдения. Вестн. Росздравнадзора. 2015; 5: 11-9.</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Ощепкова Е.В., Лазарева Н.В., Салтыкова Д.Ф., Терещенко С.Н. Первые результаты Российского Регистра ХСН. Кардиология. 2015; 55: 22-8.</mixed-citation></ref></ref-list></back></article>
